Start treatment at hematologic recovery and continue until disease progression or unacceptable toxicity.
MAINTENANCE STARTING DOSE
10 mg on Days 1-28 of repeated 28-day cycles
Capsule shown not actual size.
If tolerated, dose can be increased to 15 mg after 3 cycles
Starting dose adjustments for renal impairment:
REVLIMID DOSE MODIFICATIONS BASED ON RENAL CLEARANCE IN PATIENTS WITH MM POST AUTO-HSCT
CrCl calculated based on Cockcroft-Gault equations. Capsules shown are not actual size.
Important Dosing Information
Reference: 1. REVLIMID [package insert]. Summit, NJ: Celgene Corp.